Skip to main content

Advertisement

Log in

Intraperitoneal Versus Intravenous CPT-11 Given Intra- and Postoperatively for Peritoneal Carcinomatosis in a Rat Model

  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Purpose

Peritoneal recurrence after resection of colorectal carcinoma is still a major concern. We investigated whether the novel cytostatic drug, CPT-11 (Irinotecan), delivered intraperitoneally (i.p.) and intravenously (i.v.), could inhibit intraperitoneal tumor spread in a rat model.

Methods

We induced intraperitoneal tumor growth using a tumor cell transfer model (106 cells) and divided the rats into the following five groups of eight: group IP1, given CPT-11 i.p. immediately after intraperitoneal tumor cell transfer; group IV1, given CPT-11 i.v. immediately after intraperitoneal tumor cell transfer; group IP2, given CPT-11 i.p. on postoperative days (PODs) 5, 10, and 15; group IV2, given CPT-11 on PODs 5, 10, and 15; and a control group. The rats were killed 30 days after tumor cell transfer, and the tumor weight, number of nodes in the greater omentum and peritoneum, presence of metastases in the liver and lungs, and ascites volume were determined.

Results

CPT-11 inhibited peritoneal tumor growth significantly. The direct intraoperative intraperitoneal application induced a more pronounced effect than the early postoperative intraperitoneal application, but both these application modes were superior to the intravenous route, which had no significant effect.

Conclusion

CPT-11 was highly efficacious against peritoneal carcinomatosis in this experimental model. The combination of CPT-11 with other cytostatic agents and drugs generating different effector mechanisms may diminish or even prevent intraperitoneal tumor growth.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. LB Saltz JV Cox C Blanke LS Rosen L Fehrenbacher MJ Moore et al. (2000) ArticleTitleIrinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer N Engl J Med 343 905–14 Occurrence Handle11006366 Occurrence Handle10.1056/NEJM200009283431302 Occurrence Handle1:CAS:528:DC%2BD3cXntFOkt7Y%3D

    Article  PubMed  CAS  Google Scholar 

  2. M Salgado J Firvida J Mata S Vasquez JR Mel M Calvo et al. (2000) ArticleTitleA phase II study of weekly CPT-11 combined with folinic acid and 5-FU in pretreated colorectal cancer (CRC) patients (Abstract-296a) Proc ASCO 19 1157

    Google Scholar 

  3. RK Phillips R Hittinger L Blesovsky JS Fry LP Fielding (1984) ArticleTitleLocal recurrence following “curative” surgery for large bowel cancer: I. The overall picture Br J Surg 71 12–6 Occurrence Handle6689962 Occurrence Handle1:STN:280:DyaL2c%2FotFejsw%3D%3D

    PubMed  CAS  Google Scholar 

  4. M Pescatori C Mattana G Maria A Ferrara L Lucibello (1987) ArticleTitleOutcome of colorectal cancer Br J Surg 74 370–2 Occurrence Handle3594126 Occurrence Handle1:STN:280:DyaL2s3ktlajsw%3D%3D

    PubMed  CAS  Google Scholar 

  5. F Michelassi L Vannucci JJ Ayala R Chappel R Goldberg GE Block (1990) ArticleTitleLocal recurrence after curative resection of colorectal cancer Surgery 108 787–93 Occurrence Handle2218892 Occurrence Handle1:STN:280:DyaK3M%2FhvFyktw%3D%3D

    PubMed  CAS  Google Scholar 

  6. AW Cass RR Million WW Pfaff (1976) ArticleTitlePatterns of recurrence following surgery alone for adenocarcinoma of the colon and rectum Cancer 37 2861–5 Occurrence Handle949706 Occurrence Handle1:STN:280:DyaE283jtlKksg%3D%3D

    PubMed  CAS  Google Scholar 

  7. S Stipa V Nicolanti C Botti M Cosimelli E Mannella F Stipa et al. (1991) ArticleTitleLocal recurrence after curative resection of colorectal cancer: frequency, risk factors and treatment J Surg Oncol Suppl 2 155–60 Occurrence Handle1892525 Occurrence Handle1:STN:280:DyaK3MzmvFChtA%3D%3D

    PubMed  CAS  Google Scholar 

  8. AW Malcolm NP Perencevich RM Olson JA Hanley JT Chaffey RE Wilson (1981) ArticleTitleAnalysis of recurrence patterns following curative resection for carcinoma of the colon and rectum Surg Gynecol Obstet 152 131–6 Occurrence Handle7209752 Occurrence Handle1:STN:280:DyaL3M7ltlGgsg%3D%3D

    PubMed  CAS  Google Scholar 

  9. CG Willett JE Tepper AM Cohen E Orlow CE Welch (1984) ArticleTitleFailure patterns following curative resection of colonic carcinoma Ann Surg 200 685–90 Occurrence Handle6508395 Occurrence Handle1:STN:280:DyaL2M%2FntFeiuw%3D%3D

    PubMed  CAS  Google Scholar 

  10. AH Russell D Tong LE Dawson W Wisbeck (1984) ArticleTitleAdenocarcinoma of the proximal colon. Sites of initial dissemination and patterns of recurrence following surgery alone Cancer 200 685–90

    Google Scholar 

  11. DZ Chu NP Lang C Thompson PK Osteen KC Westbrook (1989) ArticleTitlePeritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors Cancer 63 364–7 Occurrence Handle2910444 Occurrence Handle1:STN:280:DyaL1M%2FovFGnsQ%3D%3D

    PubMed  CAS  Google Scholar 

  12. B Sadeghi C Arvieux O Glehen AC Beaujard M Rivoire J Baulieux et al. (2000) ArticleTitlePeritoneal carcinomatosis from non gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study Cancer 88 358–63 Occurrence Handle10640968 Occurrence Handle10.1002/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O Occurrence Handle1:STN:280:DC%2BD3c7gvVOntg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  13. M Pross H Lippert R Mantke S Kruger T Gunther F Marusch et al. (2001) ArticleTitleA proteinase inhibitor decrease tumor growth in a laparoscopic rat model Surg Endosc 15 882–5 Occurrence Handle11443463 Occurrence Handle1:STN:280:DC%2BD3MrksFShsA%3D%3D Occurrence Handle10.1007/s004640090029

    Article  PubMed  CAS  Google Scholar 

  14. S Guichard E Chatelut I Lochon R Bugat M Mahjoubi P Canal (1998) ArticleTitleComparison of the pharmacokinetics and efficacy of Irinotecan after administration by the intravenous versus intraperitoneal route in mice Cancer Chemother Pharmacol 42 165–70 Occurrence Handle9654118 Occurrence Handle10.1007/s002800050801 Occurrence Handle1:CAS:528:DyaK1cXjslWmu74%3D

    Article  PubMed  CAS  Google Scholar 

  15. PH Sugarbaker Y Yonemura (2001) ArticleTitlePalliation with a glimmer of hope: management of resectable gastric cancer with peritoneal carcinomatosis Hepatogastroenterology 48 1238–47 Occurrence Handle11677938 Occurrence Handle1:STN:280:DC%2BD3MrntFajsw%3D%3D

    PubMed  CAS  Google Scholar 

  16. HJ Stein SJM Kraemer H Feussner JR Siewert (1997) ArticleTitleClinical value of diagnostic laparoscopy with laparoscopic ultrasound in patients with cancer of the esophagus or cardia J Gastrointest Surg 1 167–73 Occurrence Handle9834344 Occurrence Handle10.1016/S1091-255X(97)80105-9 Occurrence Handle1:STN:280:DC%2BD28nhslSntQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  17. A Hagiwara T Takahashi O Kojima K Sawai T Yamaguchi T Yamane et al. (1992) ArticleTitleProphylaxis with carbon-absorbed mitomycin against peritoneal recurrence of gastric cancer Lancet 339 629–31 Occurrence Handle1347336 Occurrence Handle10.1016/0140-6736(92)90792-2 Occurrence Handle1:STN:280:DyaK387nslyrtw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  18. W Yu I Whang I Suh A Averbach D Chang PH Sugargbaker (1998) ArticleTitleProspective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer Ann Surg 228 347–54 Occurrence Handle9742917 Occurrence Handle10.1097/00000658-199809000-00007 Occurrence Handle1:STN:280:DyaK1cvhtlynuw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  19. PH Sugarbaker KA Jablonski (1995) ArticleTitlePrognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy Ann Surg 221 124–32 Occurrence Handle7857141 Occurrence Handle1:STN:280:DyaK2M7mtVGnsA%3D%3D

    PubMed  CAS  Google Scholar 

  20. KW Horsell S Merten P Clingan DW King DL Morris (1999) ArticleTitlePeritonectomy and intraperitoneal chemotherapy in appendical and colorectal cancer Aust N Z J Surg 69 729–32 Occurrence Handle10527351 Occurrence Handle10.1046/j.1440-1622.1999.01675.x Occurrence Handle1:STN:280:DyaK1MvlsVCktw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  21. J Fass M Jansen K Zengel T Reinecke G Asshoff V Schumpelick (1998) ArticleTitleResults of intraperitoneal active charcoal-mitomycin C therapy of stomach carcinoma with serosa invasion Langenbecks Arch Chir 115 IssueIDSuppl 1363–6

    Google Scholar 

  22. T Sautner F Hofbauer D Depisch R Schiessel R Jakesz (1994) ArticleTitleAdjuvant intraperitoneal cisplatin chemotherapy does not improve long-term survival after surgery for advanced gastric cancer J Clin Oncol 12 970–4 Occurrence Handle8164049 Occurrence Handle1:STN:280:DyaK2c3hs12ntQ%3D%3D

    PubMed  CAS  Google Scholar 

  23. HR Rosen G Jatzko S Repse S Potrc H Neudorfer P Sandbichler et al. (1998) ArticleTitleAdjuvant intraperitoneal chemotherapy with carbon-absorbed mitomycin in patients with gastic cancer: results of a randomized multicenter trial of the Austrian working group for surgical oncology J Clin Oncol 16 2733–8 Occurrence Handle9704725 Occurrence Handle1:CAS:528:DyaK1cXlsFCgu7w%3D

    PubMed  CAS  Google Scholar 

  24. S Samel A Singal H Becker S Post (2000) ArticleTitleProblems with intraperitoneal chemotherapy for advanced gastric cancer Eur J Surg Oncol 26 222–6 Occurrence Handle10753533 Occurrence Handle1:STN:280:DC%2BD3c3hvV2mtQ%3D%3D

    PubMed  CAS  Google Scholar 

  25. M Maruyama S Takamatsu N Sugano M Ebuchi M Endo Y Yuasa (1997) ArticleTitleExperimental study on intraperitoneal sequential MTX/5-FU therapy for peritoneal seeding in comparison with intravenous administration (in Japanese with English abstract) Gan to Kagakuryoho (Jpn J Cancer Chemother) 24 2131–6 Occurrence Handle1:STN:280:DyaK1c%2FkvFykug%3D%3D

    CAS  Google Scholar 

  26. W Scheithauer GV Kornek A Marczell J Karner (1998) ArticleTitleCombined intravenous and intraperitoneal chemotherapy with 5-FU + leucovorin vs 5-FU + levamisole for adjuvant therapy of resected colon carcinoma Br J Cancer 77 1349–54 Occurrence Handle9579845 Occurrence Handle1:CAS:528:DyaK1cXislChsbo%3D

    PubMed  CAS  Google Scholar 

  27. M Shiu J Fortner (1980) ArticleTitleIntraperitoneal hyperthermic treatment of implantated peritoneal cancer in rats Cancer Res 40 4081–4 Occurrence Handle7471053 Occurrence Handle1:STN:280:DyaL3M7jsFGisA%3D%3D

    PubMed  CAS  Google Scholar 

  28. L Benoit C Duvillard JL Beltramo P Brunet-Lecomte B Chauffert (2000) ArticleTitleIntraperitoneal cisplatin plus epinephrine and surgical debulking for the treatment of advanced peritoneal carcinomatosis in the rat Gastroenterol Clin Biol 24 26–30 Occurrence Handle10679584 Occurrence Handle1:CAS:528:DC%2BD3cXitVOlsL0%3D

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hribaschek, A., Kuhn, R., Pross, M. et al. Intraperitoneal Versus Intravenous CPT-11 Given Intra- and Postoperatively for Peritoneal Carcinomatosis in a Rat Model. Surg Today 36, 57–62 (2006). https://doi.org/10.1007/s00595-004-3096-7

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-004-3096-7

Key words

Navigation